In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude Tries To Get Ahead Of Questions On Durata ICD Leads

Executive Summary

St. Jude Medical hopes an independent analysis of its Optim-insulated Durata leads will address questions from the clinical community based on concerns with its earlier-generation Riata devices.

You may also be interested in...



ICD Lead Recall Could Have Come Sooner With Novel Surveillance Tool – Study

A retrospective analysis shows that a software analytics tool would have enabled earlier detection of Medtronic’s Sprint Fidelis defibrillator lead fracture issues and an earlier recall of the device, which was withdrawn from the market in 2007.

QUOTED. 12 August 2020. Rep. James Clyburn.

House Democrats criticized the administration’s response to the pandemic in a new report. See what Rep. James Clyburn, chairman of the Select Subcommittee on the Coronavirus Crisis, said about it here.

Zero Gravity Submits To NAD Review For Skin-Rejuvenating Device Claims Following FTC Referral

The Perfectio device marketer came away from the advertising industry’s self-regulatory process with a number of claims intact or mostly untouched, though it discontinued a couple going into the assessment and the National Advertising Division advised against a few others. The firm has pledged to comply “in the spirit of compromise.”

Topics

Related Companies

UsernamePublicRestriction

Register

WI965023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel